Overview


According to FutureWise analysis the market for dermal fillers in 2023 is US$ 5.41 billion, and is expected to reach US$ 10.03 billion by 2031 at a CAGR of 8.02%.

Dermal fillers are injections used to fill out wrinkles and gives a smooth appearance to the skin. They can also be used to increase the volume of facial organs. They include collagen, hyaluronic acid, calcium hydroxyl apatite and others. Dermal fillers effects can be either temporary or permanent, depending on the type of fillers and used for facial reconstruction. Dermal collagen is used for triggering dermal metabolism and its effects last for three to four months. Hyaluronic acid is used for facial reappearance and its effects last for four months to six months. Calcium hydroxylapatite is used for facial augmentation and its effect last for 18 months and polymethylmethacrylate beads are used for permanent effect.

The increasing importance of personal appearance in general population led to the potential growth of dermal fillers market. Along with this, rising awareness of minimally invasive cosmetic procedure led to rapid adoption. Further, changing demographics and rising living standards led to the potential growth of the market. Minimal invasive cosmetic procedures like dermal fillers more cost effects with fewer side effects compared to conventional cosmetic procedures. Dermal fillers market has witnessed double digit growth during the forecast period due to increasing penetration among developing countries. Additionally, increasing R D investment to strengthen the product portfolio led to the development of new products in the forecast period.

High awareness and penetration among the general population of developed economies like North America and Europe region account major share in global dermal fillers market. They are expected to remain dominant over the forecast period and witness stagnant growth rate. Asia Pacific is a fast growing region and expected to create an opportunistic space for both international and local manufacturers. Asia Pacific and Latin America is a fast growing region in the global Dermal Fillers market. Rest of the world is expected to account minor share in global market.

  • Allergan
  • Skin Vein Institute, LLC
  • Galderma Laboratories, L.P
  • Merz Pharma
  • Dr. Korman Laboratories
  • Sinclair Pharma
  • Teoxane Laboratories
  • Suneva Medical
  • SciVision Biotech Inc.
  • Medytox

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Filler Type

  • Calcium hydroxylapatite
  • Hyaluronic acid
  • Poly-alkylimide
  • Polylactic acid
  • Polymethylmethacrylate microspheres (PMMA)

By Application

  • Scar Treatment
  • Wrinkle Correction Treatment
  • Lip Enhancement
  • Restoration of Volume/Fullness
  • Others

By Product

  • Biodegradable
    • Temporary biodegradable
    • Semi-permanent biodegradable
  • Non-Biodegradable

By End-User

  • Hospital
  • Cosmetic Clinics
  • Outpatient Centres
  • Beauty Centres
  • Academics

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Global Dermal Filler Market By Filler Type, By Application, By Product, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and an overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Dermal Fillers Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Dermal Fillers Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Dermal Fillers Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Dermal Fillers Market, By Filler Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Calcium hydroxylapatite
        2. Hyaluronic acid
        3. Poly-alkylimide
        4. Polylactic acid
        5. Polymethylmethacrylate microspheres (PMMA)

  • 8.   Dermal Fillers Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Scar Treatment
        2. Wrinkle Correction Treatment
        3. Lip Enhancement
        4. Restoration of Volume/Fullness
        5. Others

  • 9.   Dermal Fillers Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Biodegradable
         1.1. Temporary biodegradable
         1.2. Semi-permanent biodegradable
        2. Non-Biodegradable

  • 10.   Dermal Fillers Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Cosmetic Clinics
        3. Outpatient Centres
        4. Beauty Centres
        5. Academics

  • 11.   North America Dermal Fillers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Dermal Fillers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Dermal Fillers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Dermal Fillers Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Allergan
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Skin Vein Institute, LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Galderma Laboratories, L.P
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merz Pharma
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Dr. Korman Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sinclair Pharma
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Teoxane Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Suneva Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. SciVision Biotech Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Medytox
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients